These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3478345)

  • 1. New developments in ELISA verification of anti-HIV screening of blood donors.
    Hellings JA; Theunissen H; Keur W; Siebelink-Liauw A
    J Virol Methods; 1987 Aug; 17(1-2):11-7. PubMed ID: 3478345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity and specificity of commercial ELISA kits for screening anti-LAV/HTLV III.
    Gürtler LG; Eberle J; Lorbeer B; Deinhardt F
    J Virol Methods; 1987 Jan; 15(1):11-23. PubMed ID: 3468119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti LAV/HTLV III antibodies in blood donors: preliminary results of pool screening of 5 samples].
    el Khoury AB; Muller A; Richard D
    Rev Fr Transfus Immunohematol; 1986 Jun; 29(3):183-92. PubMed ID: 3466317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-HTLV III ELISA and Western blot testing in a blood donor population: implications for donor notification.
    Kleinman S; Anton-Guirigis H; Culver BD; Taylor TH; Prince HE; Kaplan HS
    Vox Sang; 1986; 51(2):143-7. PubMed ID: 3535251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serology in HIV infection: comparison of indirect immunofluorescence, Western blot and enzyme immunoassay].
    Schmidt BL; Hutterer J; Kunz C; Gschnait F
    Wien Med Wochenschr; 1988 Apr; 138(8):174-80. PubMed ID: 3043921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status of current clinical tests for human immunodeficiency virus (HIV): applications and limitations.
    Houn HY; Pappas AA; Walker EM
    Ann Clin Lab Sci; 1987; 17(5):279-85. PubMed ID: 3314657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Field testing and comparative evaluation of rapid, visually read screening assays for antibody to human immunodeficiency virus.
    Spielberg F; Kabeya CM; Ryder RW; Kifuani NK; Harris J; Bender TR; Heyward WL; Quinn TC
    Lancet; 1989 Mar; 1(8638):580-4. PubMed ID: 2564112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of two ELISA kits for the demonstration of antibodies against LAV/HTLV-III].
    Heinz FX; Kunz C; Barrett N
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Apr; 264(1-2):196-200. PubMed ID: 3307232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunofluorescence tests for HIV antibody and their value as confirmatory tests.
    van der Groen G; Vercauteren G; Piot P
    J Virol Methods; 1987 Aug; 17(1-2):35-43. PubMed ID: 3312266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two commercially available anti-HIV ELISAs: Abbott HTLV III EIA and Du Pont HTLV III-ELISA.
    Burkhardt U; Mertens T; Eggers HJ
    J Med Virol; 1987 Nov; 23(3):217-24. PubMed ID: 3323415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme immunoassays for the demonstration of antibodies to HIV-2SBL-6669 and HTLV-IV (SIVmac).
    Biberfeld G; Thorstensson R; Bergström M; Naucler A; Costa CM
    AIDS; 1988 Jun; 2(3):195-9. PubMed ID: 3134913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HIV (HTLV III/LAV) serology: experiences based on more than 42,000 tests].
    Gschnait F; Schmidt BL; Schwarz T; Heinz FX; Kunz C
    Wien Klin Wochenschr; 1987 Aug; 99(15):536-9. PubMed ID: 3310415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Specificity of a new test for detection of antibodies to HIV-1/-2 in blood donors].
    Saadé C; Wüst T
    Infusionsther Transfusionsmed; 1996 Jun; 23(3):133-7. PubMed ID: 8924748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serologic testing for human immunodeficiency virus antibodies.
    Steckelberg JM; Cockerill FR
    Mayo Clin Proc; 1988 Apr; 63(4):373-80. PubMed ID: 3162545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of blood centers in the screening of blood donors for viral markers.
    Dogbe EE; Arthur F
    Pan Afr Med J; 2015; 20():119. PubMed ID: 26090067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing for antibodies to AIDS-associated retrovirus (HTLV-III/LAV) by indirect fixed cell immunofluorescence: specificity, sensitivity, and applications.
    Hedenskog M; Dewhurst S; Ludvigsen C; Sinangil F; Rodriguez L; Wu YT; Volsky DJ
    J Med Virol; 1986 Aug; 19(4):325-34. PubMed ID: 3018138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HTLV-III screening of blood donors.
    Kühnl P; Seidl S; Holzberger G
    Vox Sang; 1986; 51 Suppl 1():15-20. PubMed ID: 3017001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel agglutination test for the human immunodeficiency virus antibody: a comparative study with enzyme-linked immunosorbent assay and immunofluorescence.
    Yoshida T; Matsui T; Kobayashi S; Harada S; Kurimura T; Hinuma Y; Yamamoto N
    Jpn J Cancer Res; 1986 Dec; 77(12):1211-3. PubMed ID: 3102425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HTLV-1 in Switzerland: low prevalence of specific antibodies in HIV risk groups, high prevalence of cross-reactive antibodies in normal blood donors.
    Schüpbach J; Baumgartner A; Tomasik Z
    Int J Cancer; 1988 Dec; 42(6):857-62. PubMed ID: 3192331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-directed ELISA with synthetic peptides representing the HIV transmembrane glycoprotein.
    Chiodi F; von Gegerfeldt A; Albert J; Fenyö EM; Gaines H; von Sydow M; Biberfeld G; Parks E; Norrby E
    J Med Virol; 1987 Sep; 23(1):1-9. PubMed ID: 3500271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.